The Toronto-based firm, known for its extensive line of vitamins and natural supplements, disclosed the development late Wednesday. While the board has entered into discussions with interested parties, leadership cautioned that these negotiations remain preliminary with no guarantee of a definitive transaction. Should these talks fail to yield a sale, the board maintains full confidence in its existing strategic roadmap to drive growth independently.